Cardiac radioablation in the treatment of ventricular tachycardia

Clinical and Translational Radiation Oncology

Terence Williams¹  Rahul N. Prasad²  Michael Siedow²  Emefah Loccoh²  Jeremy Brownstein²  Matthew S. Tong³  Toshimasa Okabe³  Muhammad R. Afzal³  Thura T. Harfi³ 

[1] Department of Radiation Oncology, City of Hope National Medical Center, Duarte, CA, USA;Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, USA;Division of Cardiovascular Medicine, The Ohio State University Medical Center, Columbus, OH, USA;

关键词: Cardiac radioablation;    SBRT;    Ventricular tachycardia;    Cardiac mapping;    Cardiac arrhythmias;   

DOI  :  

来源: DOAJ

【 摘 要 】

Cardiac radioablation with SBRT is a very promising non-invasive modality for the treatment of refractory VT and potentially other cardiac arrhythmias. Initial reports indicate that it is relatively safe and associated with excellent responses, particularly in reduction of ICD-related events, need for anti-arrhythmic medications, and resulting in significantly improved quality of life for patients. Establishment of objective criteria for candidates for cardiac radioablation will accelerate the adoption of this important radiation therapy modality in the treatment of refractory VT and other cardiac arrhythmias in the coming years. In addition, in order to develop more prospective safety and efficacy data, treatment of patients should ideally be performed in the context of clinical trials or prospective registries at, or in collaboration with, experienced centers. Taken together, the future of cardiac radioablation is rich and worthy of further investigation to become a standard treatment in the armamentarium against refractory VT.

【 授权许可】

Unknown